Hepatoprotective Effects of Flavonoids Against Acetaminophen Toxicity
- 1Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada
- 2School of Pharmacy, Xi’an Jiaotong University, Xi’an 710061, China
Abstract
Acetaminophen (APAP) is a common analgesic and antipyretic agent; however, overdose can cause severe liver injury requiring transplantation or resulting in death. Currently, N-acetylcysteine (NAC) is the standard first-line treatment for APAP-induced liver injury (AILI). There is ongoing interest in exploring complementary hepatoprotective compounds, such as plant-derived flavonoids and their mechanisms of action to improve our understanding and management of AILI. This review aims to identify key flavonoids studied to date in the setting of AILI and their proposed mechanisms. A systematic search was conducted across PubMed, Scopus, Web of Science, and Embase. Eligible studies were restricted to murine models of APAP overdose where isolated flavonoids were administered therapeutically post-APAP-injury. From 1752 identified records, 18 studies investigating sixteen distinct flavonoids met the inclusion criteria. Their major mechanisms of actions were identified which include antioxidation, anti-inflammation, modulation of APAP metabolism, and inhibition of cell death pathways. Furthermore, emerging nano-delivery systems markedly enhanced flavonoid solubility and therapeutic efficacy. Although these findings highlight promising candidates and novel therapeutic targets for AILI, clinical trials are essential to establish human efficacy and safety.
Related
- Comparative hepatoprotective efficacy of spirulina polysaccharides and crude spirulina against metalaxyl-m toxicity via modulation of oxidative stress and Nrf2/NF-κB gene expression
- Gene expression, Antioxidant Responses, and metabolomic Profiling Reveal Chlorella vulgaris Mediated Protection against acetaminophen and microplastic Co-toxicity in Oreochromis niloticus
- Hepatoprotective and pancreatoprotective effects of Arctium lappa root extract in valproic acid–induced toxicity: biochemical, histopathological, and immunohistochemical analysis
- Differential Protection against Acetaminophen-induced Liver and Kidney Injury by N-Acetylcysteine and Fomepizole in Female Mice
- Integrated proteomic and metabolomic analysis reveals the mechanism of astragalus complanatus flavonoids against liver fibrosis in rats
BibTeX
@article{panesar2026hepatoprotective,
title = {{Hepatoprotective Effects of Flavonoids Against Acetaminophen Toxicity}},
author = {Arshdeep Panesar and Rukhsana Aslam and Nabila Jahan and Cynthia T. Luk and Apu Chowdhury},
journal = {Molecules (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/molecules31193527},
url = {https://europepmc.org/article/PMC/PMC13666650},
note = {CC BY},
}
RIS
TY - JOUR
TI - Hepatoprotective Effects of Flavonoids Against Acetaminophen Toxicity
AU - Arshdeep Panesar
AU - Rukhsana Aslam
AU - Nabila Jahan
AU - Cynthia T. Luk
AU - Apu Chowdhury
PY - 2026
DA - 2026/10/01
JO - Molecules (Basel, Switzerland)
DO - 10.3390/molecules31193527
UR - https://europepmc.org/article/PMC/PMC13666650
AB - Acetaminophen (APAP) is a common analgesic and antipyretic agent; however, overdose can cause severe liver injury requiring transplantation or resulting in death. Currently, N-acetylcysteine (NAC) is the standard first-line treatment for APAP-induced liver injury (AILI). There is ongoing interest in exploring complementary hepatoprotective compounds, such as plant-derived flavonoids and their mechanisms of action to improve our understanding and management of AILI. This review aims to identify key flavonoids studied to date in the setting of AILI and their proposed mechanisms. A systematic search was conducted across PubMed, Scopus, Web of Science, and Embase. Eligible studies were restricted to murine models of APAP overdose where isolated flavonoids were administered therapeutically post-APAP-injury. From 1752 identified records, 18 studies investigating sixteen distinct flavonoids met the inclusion criteria. Their major mechanisms of actions were identified which include antioxidation, anti-inflammation, modulation of APAP metabolism, and inhibition of cell death pathways. Furthermore, emerging nano-delivery systems markedly enhanced flavonoid solubility and therapeutic efficacy. Although these findings highlight promising candidates and novel therapeutic targets for AILI, clinical trials are essential to establish human efficacy and safety.
SN - 1420-3049
ER -